Assessing the MUC5B promoter variant in a large cohort of systemic sclerosis-associated interstitial lung disease
Open Access
Abstract
Objective: The common gain-of-function variant rs35705950, located in the promoter of MUC5B gene, has been strongly associated with interstitial lung diseases (ILDs) of different aetiology, such as idiopathic pulmonary fibrosis (IPF) and rheumatoid arthritis-associated ILD (RA-ILD). In this study, we aimed to investigate the association of this variant and its nearby single nucleotide polymorphisms (SNPs) in the largest cohort of systemic sclerosis-associated ILD (SSc-ILD) to date. Methods: Samples were collected from blood/saliva, followed by DNA extraction and genotyping using SNP arrays. Data for rs35705950 and additional 903 variants within 100 Kb were obtained using genomic imputation. Subsequently, we tested their association in a meta-analysis to increase the consistency of the results, including 10 European ancestry cohorts comprising 2363 patients with SSc-ILD, 3526 SSc patients without ILD and 15 076 controls. Results: Meta-analysis showed no significant association between rs35705950 and SSc-ILD, either comparing patients with SSc with and without ILD (p value: 0.588, OR: 1.05, 95% CI: 0.87 to 1.27) nor patients with SSc-ILD with controls (p value: 0.061, OR: 1.16, 95% CI: 0.99 to 1.36). Moreover, none of the additional 903 variants tested in the genomic region reached statistical significance. Conclusion: Despite analysing the largest and most statistically powered SSc-ILD cohort to date, we found no evidence of association between the MUC5B promoter variant rs35705950 and its surrounding SNPs with SSc-ILD. These results suggest that the pathogenic mechanisms underlying SSc-ILD may only partially overlap with those of other similar ILDs, such as IPF or RA-ILD. This highlights the need for further studies regarding their genetic architecture.Keywords
Funding Information
- Spanish Ministry of University (FPU21/02746)
- Spanish Ministry of Science Innovation and Universities (FPU22/01652, PID2022-139292OB-I00, PREP2022-000747)
- Congressionally Directed Medical Research Programs (DoD-W81XWH-22-1-0162)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR081280, R33AR078078)
- NIH (R61AR078078)
This publication has 20 references indexed in Scilit:
- Shared genetic predisposition in rheumatoid arthritis-interstitial lung disease and familial pulmonary fibrosisEuropean Respiratory Journal, 2017
- Pulmonary fibrosis in the era of stratified medicineThorax, 2016
- Second-generation PLINK: rising to the challenge of larger and richer datasetsGigaScience, 2015
- The MUC5B Variant Is Associated with Idiopathic Pulmonary Fibrosis but Not with Systemic Sclerosis Interstitial Lung Disease in the European Caucasian PopulationPLOS ONE, 2013
- Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosisThorax, 2013
- The Pulmonary Fibrosis-Associated MUC5B Promoter Polymorphism Does Not Influence the Development of Interstitial Pneumonia in Systemic SclerosisChest, 2012
- Random-Effects Model Aimed at Discovering Associations in Meta-Analysis of Genome-wide Association StudiesThe American Journal of Human Genetics, 2011
- A CommonMUC5BPromoter Polymorphism and Pulmonary FibrosisNew England Journal of Medicine, 2011
- GCTA: A Tool for Genome-wide Complex Trait AnalysisThe American Journal of Human Genetics, 2011
- Criteria for the classification of early systemic sclerosis.2001